Knoll Capital Management, LLC has filed a restatement of its Form 13F-HR for the period ending June 30, 2026. The filing, signed by President Fred Knoll, details the firm's equity portfolio as of the specified date.
The report lists 37 total holdings. The largest position disclosed is in Aldeyra Therapeutics Inc., where Knoll Capital holds 5,475,516 shares. Other significant positions include MeiraGTX Holdings with 1,250,000 shares and Entera Bio Ltd with 5,881,879 shares.
The portfolio also includes a variety of precious metals and royalty companies. Centerra Gold Inc. is held at 359,000 shares, while SSR Mining and Triple Flag Precious Metals are held at 245,000 and 115,000 shares, respectively. The firm also lists positions in Northrop Grumman Corp and Booz Allen Hamilton.
The filing indicates that the firm holds no positions in Abeona Therapeutics or Abivax SA as of the reporting period.
